ConMed (NSDQ:CNMD) today responded to a long and critical letter from Voce Capital Management issued last week that demanded steps toward a strategic exit and the end "a culture of nepotism, patronage and dystopian corporate governance."
Wall Street Beat
Hologic losses surge on impairment charge, but Q4 beats The Street
Listen to Hologic’s Q4 2013 earnings call
Mindray lowers full year guidance on slowdown in China
EnteroMedics Q3 losses widen as company continues chasing FDA approval
Listen to NxStage Medical’s Q3 2013 earnings call
NxStage tanks on lowered 2013 guidance amid weak home hemo results
Medtech analyst chides Erin Brockovich’s crusade against Bayer’s birth control implant
BD announces management changes as Q4 profits slide on legal settlement
Becton Dickinson & Co. (NYSE:BDX) beat Wall Street’s estimates for its 4th quarter of 2013 and handed out a couple of promotions during the company’s quarterly conference call with investors.